上海招聘

岗位名称：药物发现主任科学家/高级科学家

职责概要：

负责抗体筛选到候选抗体优化的全过程。同时担负内部研发和外部合作的工作。

岗位职责：

要求具有深厚的治疗抗体研发经验。包括抗原设计，筛选方案建立，抗体鉴定，以及序列分析及优化等。噬菌体展示相关工作经验为加分项。

任职资格：

生物学，免疫学或相关专业博士或具有四年以上工作经验的硕士。

良好的英语读写沟通技能。

Position: Principle Scientist/Senior Scientist (Antibody Discovery)

Job Summary:

The candidate will be responsible for leading antibody discovery projects from hit generation to lead optimization stage. The candidate will not only lead internal efforts but also work closely with outside collaborators.

Responsibility：

The position requires in depth experience in therapeutics antibody discovery. This includes antigen design, assay development, antibodies characterization, sequences analysis and optimization, etc. Experience in phage library construction and selection is a plus.

Qualification:

Minimum requirements: PhD degree in biology, immunology or other related major, or MS degree with +4 years related working experience.

Good written and verbal communication skills in English.

 

岸迈生物是一家创新型国际化生物技术企业，在上海和苏州分别设有研发中心和中试基地，专注于利用自主知识产权的双特异性抗体技术平台FIT-Ig进行创新生物药的研究和开发。FIT-Ig技术平台能够通过分子生物学手段将两个单抗序列糅合在一起形成一种结构独特的双特异性抗体，是全球***的既不需要任何氨基酸突变、也不包含连接肽链及任何非抗体序列的双特异性抗体技术，具备很高的成药性和产业化效率。基于FIT-Ig平台技术，岸迈生物正在针对肿瘤免疫和其他临床需求高的领域进行双特异性抗体系列原创产品的开发。岸迈生物同时也在通过全球范围内的技术授权、合作开发等多种形式实现平台的战略发展和产品多元化布局。
公司网页：**************
简历投递：hr@epimab.com
About EpimAb Biotherapeutic
EpimAb Biotherapeutics is a privately-owned biopharmaceutical R&D company based in Shanghai？ with a proprietary unique and efficient technology called FIT-Ig (Fabs-In-Tandem Immunoglobulin) to generate bispecific molecules with antibody-like properties， without any mutations, peptide linkers, or non-Ig sequences. With this platform, EpimAb is creating a pipeline of its own novel bispecific antibody therapeutics focused around immuno-oncology and other areas of high value to patients. EpimAb is also committed to diversifying its pipeline through selective licensing of its platform to partners worldwide. For further information, please visit **************
Web:**************
Email:hr@epimab.com